News & Updates
Filter by Specialty:
Biologic DMARDs offer clinical benefits in adult-onset Still disease
Use of biologic disease-modifying antirheumatic drugs (bDMARDs), particularly tocilizumab (TCZ), anakinra (ANK), and canakinumab (CNK), appears safe and effective in the treatment of adult-onset Still disease (AOSD), results of a systematic review and meta-analysis have shown.
Biologic DMARDs offer clinical benefits in adult-onset Still disease
15 May 2024
RSV vaccine plus flu or COVID-19 shots safe, feasible in older adults
Coadministration of mRNA-1345, a respiratory syncytial virus (RSV) vaccine, with an influenza (flu) or a COVID-19 vaccine in older adults exhibits good tolerability and has an acceptable reactogenicity profile, according to a US study presented at ESCMID Global Congress 2024.
RSV vaccine plus flu or COVID-19 shots safe, feasible in older adults
13 May 2024
Psilocybin may help ease depression symptoms
Treatment with psilocybin significantly improves the symptoms of depression, particularly when using self-report scales and when individuals have used psychedelics in the past, results of a systematic review and meta-analysis have shown.